Most pet diabetes occurs in middle aged and middle aged cats, with females at twice the rate of males; obese males are more likely to develop diabetes than females. The symptoms of pet diabetes are mainly shown in the following: Abnormal increase in water consumption and urine output, animals become hungry, will always want to eat, will drink more and more urine will cause serious dehydration, cataracts in both eyes.
This report contains market size and forecasts of Pet Diabetes Care in Global, including the following market information:
Global Pet Diabetes Care Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Pet Diabetes Care market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pet Diabetes Care include UltiMed, Boehringer Ingelheim Vetmedica, Merck, Apotex, Zoetis, BD, Henry Schein Animal Health and FitBark, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pet Diabetes Care companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Diabetes Care Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Pet Diabetes Care Market Segment Percentages, by Type, 2021 (%)
Drugs
Devices
Others
Global Pet Diabetes Care Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Pet Diabetes Care Market Segment Percentages, by Application, 2021 (%)
Canine
Feline
Global Pet Diabetes Care Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Pet Diabetes Care Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Diabetes Care revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Pet Diabetes Care revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
UltiMed
Boehringer Ingelheim Vetmedica
Merck
Apotex
Zoetis
BD
Henry Schein Animal Health
FitBark